Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2023-06-02 Purchase | 2023-06-06 9:00 pm | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 30,000 | $0.431 | $12,930 | 1,327,174 (Direct) | View |
| 2022-10-17 Purchase | 2022-10-19 5:29 pm | Pasithea Therapeutics Corp. | KTTA | Delaney David Concord IP2 Ltd. Elderhill Corp Member of 10% owner group | 1,000 | $1.11 | $1,110 | 227,521 (Indirect) | View |
| 2022-09-28 Purchase | 2022-09-30 4:36 pm | Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group | 64,357 | $1.1856 | $76,299 | 1,788,415 (Indirect) | View |
| 2022-09-01 Purchase | 2022-09-06 5:03 pm | Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group | 88,901 | $1.129 | $100,367 | 1,724,058 (Indirect) | View |
| 2022-08-29 Purchase | 2022-08-31 4:32 pm | Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group | 22,828 | $1.1518 | $26,293 | 1,635,157 (Indirect) | View |
| 2022-08-19 Purchase | 2022-08-26 4:30 pm | Pasithea Therapeutics Corp. | KTTA | Geller Avi Leonite Fund I LP Leonite Capital LLC Member of 10% owner group | 54,644 | $1.2982 | $70,939 | 1,089,346 (Indirect) | View |
| 2022-08-17 Purchase | 2022-08-18 7:35 pm | Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group | 155,773 | $1.2087 | $188,283 | 1,611,329 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 26,669 | $0 | 26,669 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 15,927 | $0 | 15,927 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Leahy Emer Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Currie Graeme Martin Chief Development Officer | 5,938 | $0 | 5,938 (Direct) | View |
| 2024-03-01 Option Award(A) | 2024-04-05 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:47 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:46 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 15,927 | $0 | 15,927 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:46 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director | 5,000 | $0 | 5,000 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:46 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 26,669 | $0 | 26,669 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:46 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Leahy Emer Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 7,500 | $0 | 7,500 (Direct) | View |
| 2024-03-01 Option Award | 2024-03-01 9:45 pm | N/A 2034-02-28 | Pasithea Therapeutics Corp. | KTTA | Currie Graeme Martin Chief Development Officer | 5,938 | $0 | 5,938 (Direct) | View |
Ownership | 2023-07-03 5:00 pm | 2023-06-30 2033-02-23 | Pasithea Therapeutics Corp. | KTTA | Currie Graeme Martin Chief Development Officer | 0 | $0 | 300,000 (Direct) | View |
Ownership | 2023-02-14 6:15 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | PD Joint Holdings LLC Series 2016-A Manning Paul B Manning Bradford Tiger Lily Capital LLC 10% Owner | 0 | $0 | 3,408,696 (Direct) | View |
| 2022-11-28 Option Award | 2022-11-28 4:00 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 5,000 | $0.98 | 1,287,174 (Direct) | View |
| 2022-11-23 Option Award | 2022-11-28 4:00 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 3,000 | $1.03 | 819,206 (Direct) | View |
| 2022-11-23 Option Award | 2022-11-28 4:00 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 5,000 | $1 | 819,206 (Direct) | View |
| 2022-11-23 Option Award | 2022-11-28 4:00 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 1,206 | $1.02 | 819,206 (Direct) | View |
| 2022-11-22 Option Award | 2022-11-22 4:10 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 5,000 | $0.99 | 1,282,174 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-17 4:34 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 40,000 | $1.06 | 150,000 (Direct) | View |
| 2021-08-02 Option Award | 2022-11-17 4:34 pm | 2022-08-02 2031-08-02 | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 100,000 | $0 | 150,000 (Direct) | View |
| 2022-11-15 Option Award | 2022-11-17 4:34 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Dumesnil Simon Director | 10,000 | $1.07 | 150,000 (Direct) | View |
| 2022-10-26 Option Award | 2022-10-26 5:35 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 5,000 | $1.1 | 1,277,174 (Direct) | View |
| 2022-10-21 Option Award | 2022-10-24 10:15 am | 2023-10-21 2032-10-21 | Pasithea Therapeutics Corp. | KTTA | Novak Alfred J Director | 100,000 | $0 | 100,000 (Direct) | View |
| 2022-10-21 Option Award | 2022-10-21 5:05 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 600 | $1.08 | 810,000 (Direct) | View |
| 2022-10-21 Option Award | 2022-10-21 5:05 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Marques Tiago Chief Executive Officer | 4,400 | $1.07 | 810,000 (Direct) | View |
| 2022-10-17 Option Award | 2022-10-17 6:11 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 9,000 | $1.13 | 1,272,174 (Direct) | View |
| 2022-10-17 Option Award | 2022-10-17 6:11 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 1,000 | $1.14 | 1,272,174 (Direct) | View |
| 2022-10-11 Option Award | 2022-10-12 8:15 pm | 2023-10-11 2032-10-11 | Pasithea Therapeutics Corp. | KTTA | Schneiderman Daniel H Chief Financial Officer | 300,000 | $0 | 300,000 (Direct) | View |
Ownership | 2022-08-16 5:56 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Delaney David Concord IP2 Ltd. Elderhill Corp Member of 10% owner group | 0 | $0 | 226,521 (Indirect) | View |
Ownership | 2022-08-15 06:13 am | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Shahinian Eric Camac Capital LLC Camac Fund LP Camac Partners LLC Member of 10% owner group | 0 | $0 | 1,455,556 (Indirect) | View |
Ownership | 2022-08-15 06:12 am | N/A N/A | Pasithea Therapeutics Corp. | KTTA | Geller Avi Leonite Capital LLC Member of 10% owner group 10% Owner | 0 | $0 | 1,034,702 (Indirect) | View |
| 2022-06-29 Option Award | 2022-06-30 4:15 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 5,000 | $1 | 1,272,174 (Direct) | View |
| 2022-06-28 Option Award | 2022-06-30 4:15 pm | N/A N/A | Pasithea Therapeutics Corp. | KTTA | STEINMAN LAWRENCE Director | 5,000 | $1.02 | 1,272,174 (Direct) | View |